RT @CVRinfo: *New Paper* from @emcat1 and @JTSglobalhealth among others discussing Glasgow Early Treatment Arm Favirpiravir for adults with…
RT @CVRinfo: *New Paper* from @emcat1 and @JTSglobalhealth among others discussing Glasgow Early Treatment Arm Favirpiravir for adults with…
RT @NHSResearchScot: The trial - a collaboration between @CRUK_GlasgowCTU, @NHSGGC and @UofGlasgow, funded by @CSO_Scotland - will test if…
RT @CRUK_GlasgowCTU: A summary of the #GETAFIX trial is available here: https://t.co/dxlD1152Vn https://t.co/ut9R6FneNX
Great to work with @CRUK_GlasgowCTU on this #GETAFIX
Great to work with @CRUK_GlasgowCTU and @NHSGGC on GETAFIX trial @CSO_Scotland @UofGlasgow @fujifilm #Favipiravir
RT @CRUK_GlasgowCTU: A summary of the #GETAFIX trial is available here: https://t.co/dxlD1152Vn https://t.co/ut9R6FneNX
RT @CRUK_GlasgowCTU: A summary of the #GETAFIX trial is available here: https://t.co/dxlD1152Vn https://t.co/ut9R6FneNX
The trial - a collaboration between @CRUK_GlasgowCTU, @NHSGGC and @UofGlasgow, funded by @CSO_Scotland - will test if the drug favipiravir is a more effective treatment for #COVID19 infection in patients at an early stage, compared to current standard care
A summary of the #GETAFIX trial is available here: https://t.co/dxlD1152Vn https://t.co/ut9R6FneNX